Moran Wealth Management LLC bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 58,072 shares of the company's stock, valued at approximately $3,977,000.
Other large investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC boosted its stake in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after buying an additional 143 shares during the last quarter. Guggenheim Capital LLC boosted its holdings in Henry Schein by 2.5% in the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock worth $445,000 after purchasing an additional 159 shares during the period. Metis Global Partners LLC boosted its holdings in Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock worth $291,000 after purchasing an additional 187 shares during the period. UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Finally, Sanctuary Advisors LLC boosted its holdings in Henry Schein by 5.0% in the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after purchasing an additional 203 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.
Henry Schein Price Performance
NASDAQ:HSIC traded up $0.12 during trading hours on Friday, reaching $73.27. The company had a trading volume of 2,247,820 shares, compared to its average volume of 1,721,643. The stock has a 50-day moving average of $69.76 and a two-hundred day moving average of $71.23. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The firm has a market capitalization of $8.92 billion, a PE ratio of 22.90, a PEG ratio of 2.36 and a beta of 0.86. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50.
Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The firm had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period in the prior year, the business posted $1.10 earnings per share. The business's revenue was down .1% compared to the same quarter last year. Analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.
Analyst Ratings Changes
HSIC has been the subject of a number of research reports. Barrington Research decreased their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Wells Fargo & Company reduced their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $79.30.
Read Our Latest Analysis on Henry Schein
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.